FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306292605> ?p ?o ?g. }

• W4306292605 endingPage "jrheum.220261" @default.
• W4306292605 startingPage "jrheum.220261" @default.
• W4306292605 abstract "To develop Canadian recommendations for the screening, monitoring, and treatment of uveitis associated with juvenile idiopathic arthritis (JIA).Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach. A working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists, and 3 caregiver/patient representatives reviewed recent American College of Rheumatology (ACR)/Arthritis Foundation (AF) recommendations and worked in pairs to develop evidence-to-decision (EtD) tables. A survey to assess agreement and recommendations requiring group discussion was completed. EtD tables were presented, discussed, and voted upon at a virtual meeting, to produce the final recommendations. A health equity framework was applied to all aspects of the adolopment process including the EtD tables, survey responses, and virtual meeting discussion.The survey identified that 7 of the 19 recommendations required rigorous discussion. Seventy-five percent of working group members attended the virtual meeting to discuss controversial topics as they pertained to the Canadian environment, including timing to first eye exam, frequency of screening, escalation criteria for systemic and biologic therapy, and the role of nonbiologic therapies. Equity issues related to access to care and advanced therapeutics across Canadian provinces and territories were highlighted. Following the virtual meeting, 5 recommendations were adapted, 2 recommendations were removed, and 1 was developed de novo.Recommendations for JIA-associated uveitis were adapted to the Canadian context by a working group of pediatric rheumatologists, ophthalmologists with expertise in the management of uveitis, and parent/patient input, taking into consideration cost, equity, and access." @default.
• W4306292605 created "2022-10-15" @default.
• W4306292605 creator A5002127968 @default.
• W4306292605 creator A5002183437 @default.
• W4306292605 creator A5015100778 @default.
• W4306292605 creator A5015427405 @default.
• W4306292605 creator A5022419667 @default.
• W4306292605 creator A5024206456 @default.
• W4306292605 creator A5032187087 @default.
• W4306292605 creator A5034266471 @default.
• W4306292605 creator A5034783558 @default.
• W4306292605 creator A5035148024 @default.
• W4306292605 creator A5036246918 @default.
• W4306292605 creator A5037002716 @default.
• W4306292605 creator A5037962183 @default.
• W4306292605 creator A5038967140 @default.
• W4306292605 creator A5043044280 @default.
• W4306292605 creator A5044190110 @default.
• W4306292605 creator A5048675329 @default.
• W4306292605 creator A5050758134 @default.
• W4306292605 creator A5072130548 @default.
• W4306292605 creator A5074108112 @default.
• W4306292605 creator A5079393057 @default.
• W4306292605 creator A5082232958 @default.
• W4306292605 creator A5082443629 @default.
• W4306292605 creator A5086014360 @default.
• W4306292605 creator A5090017681 @default.
• W4306292605 date "2022-10-15" @default.
• W4306292605 modified "2023-10-16" @default.
• W4306292605 title "Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis" @default.
• W4306292605 doi "https://doi.org/10.3899/jrheum.220261" @default.
• W4306292605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36243417" @default.
• W4306292605 hasPublicationYear "2022" @default.
• W4306292605 type Work @default.
• W4306292605 citedByCount "1" @default.
• W4306292605 countsByYear W43062926052023 @default.
• W4306292605 crossrefType "journal-article" @default.
• W4306292605 hasAuthorship W4306292605A5002127968 @default.
• W4306292605 hasAuthorship W4306292605A5002183437 @default.
• W4306292605 hasAuthorship W4306292605A5015100778 @default.
• W4306292605 hasAuthorship W4306292605A5015427405 @default.
• W4306292605 hasAuthorship W4306292605A5022419667 @default.
• W4306292605 hasAuthorship W4306292605A5024206456 @default.
• W4306292605 hasAuthorship W4306292605A5032187087 @default.
• W4306292605 hasAuthorship W4306292605A5034266471 @default.
• W4306292605 hasAuthorship W4306292605A5034783558 @default.
• W4306292605 hasAuthorship W4306292605A5035148024 @default.
• W4306292605 hasAuthorship W4306292605A5036246918 @default.
• W4306292605 hasAuthorship W4306292605A5037002716 @default.
• W4306292605 hasAuthorship W4306292605A5037962183 @default.
• W4306292605 hasAuthorship W4306292605A5038967140 @default.
• W4306292605 hasAuthorship W4306292605A5043044280 @default.
• W4306292605 hasAuthorship W4306292605A5044190110 @default.
• W4306292605 hasAuthorship W4306292605A5048675329 @default.
• W4306292605 hasAuthorship W4306292605A5050758134 @default.
• W4306292605 hasAuthorship W4306292605A5072130548 @default.
• W4306292605 hasAuthorship W4306292605A5074108112 @default.
• W4306292605 hasAuthorship W4306292605A5079393057 @default.
• W4306292605 hasAuthorship W4306292605A5082232958 @default.
• W4306292605 hasAuthorship W4306292605A5082443629 @default.
• W4306292605 hasAuthorship W4306292605A5086014360 @default.
• W4306292605 hasAuthorship W4306292605A5090017681 @default.
• W4306292605 hasBestOaLocation W43062926051 @default.
• W4306292605 hasConcept C118487528 @default.
• W4306292605 hasConcept C126322002 @default.
• W4306292605 hasConcept C127413603 @default.
• W4306292605 hasConcept C147176958 @default.
• W4306292605 hasConcept C151730666 @default.
• W4306292605 hasConcept C17744445 @default.
• W4306292605 hasConcept C1862650 @default.
• W4306292605 hasConcept C198451711 @default.
• W4306292605 hasConcept C199539241 @default.
• W4306292605 hasConcept C2776194053 @default.
• W4306292605 hasConcept C2777286243 @default.
• W4306292605 hasConcept C2779343474 @default.
• W4306292605 hasConcept C2779473830 @default.
• W4306292605 hasConcept C512399662 @default.
• W4306292605 hasConcept C71924100 @default.
• W4306292605 hasConcept C86803240 @default.
• W4306292605 hasConceptScore W4306292605C118487528 @default.
• W4306292605 hasConceptScore W4306292605C126322002 @default.
• W4306292605 hasConceptScore W4306292605C127413603 @default.
• W4306292605 hasConceptScore W4306292605C147176958 @default.
• W4306292605 hasConceptScore W4306292605C151730666 @default.
• W4306292605 hasConceptScore W4306292605C17744445 @default.
• W4306292605 hasConceptScore W4306292605C1862650 @default.
• W4306292605 hasConceptScore W4306292605C198451711 @default.
• W4306292605 hasConceptScore W4306292605C199539241 @default.
• W4306292605 hasConceptScore W4306292605C2776194053 @default.
• W4306292605 hasConceptScore W4306292605C2777286243 @default.
• W4306292605 hasConceptScore W4306292605C2779343474 @default.
• W4306292605 hasConceptScore W4306292605C2779473830 @default.
• W4306292605 hasConceptScore W4306292605C512399662 @default.
• W4306292605 hasConceptScore W4306292605C71924100 @default.
• W4306292605 hasConceptScore W4306292605C86803240 @default.
• W4306292605 hasLocation W43062926051 @default.
• W4306292605 hasLocation W43062926052 @default.
• W4306292605 hasOpenAccess W4306292605 @default.

• next